FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1230117002: Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5067242010 Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5067243017 Bacitracin and neomycin and sulfacetamide only product in cutaneous dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) est un(e) (attribut) Product containing only bacitracin and neomycin and sulfacetamide (medicinal product) true Inferred relationship Some
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) est un(e) (attribut) Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form true Inferred relationship Some
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) Plays role Antibacterial therapeutic role (role) true Inferred relationship Some
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) a pour principe actif (attribut) Sulfacetamide (substance) true Inferred relationship Some 1
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) a pour principe actif (attribut) Neomycin (substance) true Inferred relationship Some 2
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) a pour principe actif (attribut) bacitracine (substance) true Inferred relationship Some 3
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) a une forme pharmaceutique (attribut) forme cutanée true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder est un(e) (attribut) True Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form) Inferred relationship Some

This concept is not in any reference sets

Back to Start